SCHEMBL19397397

SCHEMBL19397397

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5ccc6ccccc6c5)cc4)nc(-c4ccc5c(c4)oc4ccccc45)n3)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.49
CYP1B1 Q16678 1/20 0.49
HCRTR1 O43613 1/20 0.42
MEN1 O00255 7/20 0.42
KMT2A Q03164 7/20 0.42
ALDH1A1 P00352 5/20 0.42
MAPT P10636 5/20 0.42
HPGD P15428 4/20 0.42
NTSR1 P30989 1/20 0.42
KDM4E B2RXH2 4/20 0.41
CYP1A2 P05177 3/20 0.41
TP53 P04637 2/20 0.41
HSD17B10 Q99714 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MMP12 P39900 1/20 0.41
MMP13 P45452 1/20 0.41
LMNA P02545 2/20 0.40
AHR P35869 1/20 0.40
CTRC Q99895 1/20 0.39
PGR P06401 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22104542 1.00 CYP1A1 (0.49) CYP1A1CYP1B1HCRTR1MEN1KMT2A
SCHEMBL15501394 0.99 CYP1A1 (0.48) CYP1A1CYP1B1HCRTR1MEN1KMT2A
SCHEMBL15501414 0.99 CYP1A1 (0.48) CYP1A1CYP1B1HCRTR1MEN1KMT2A
SCHEMBL19397520 0.96 CYP1A1 (0.49) CYP1A1CYP1B1HCRTR1MEN1KMT2A
SCHEMBL19397617 0.96 CYP1A1 (0.46) CYP1A1CYP1B1HCRTR1MEN1KMT2A
SCHEMBL15501538 0.96 CYP1A1 (0.54) CYP1A1CYP1B1HCRTR1MEN1KMT2A
SCHEMBL22309452 0.95 CYP1A1 (0.48) CYP1A1CYP1B1HCRTR1MEN1KMT2A
SCHEMBL24585928 0.95 CYP1A1 (0.49) CYP1A1CYP1B1HCRTR1MEN1KMT2A
SCHEMBL22309654 0.94 CYP1A1 (0.49) CYP1A1CYP1B1HCRTR1MEN1KMT2A
SCHEMBL24586649 0.93 HCRTR1 (0.45) CYP1A1CYP1B1HCRTR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2020-03-03 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same C1S, AOC2, L1CAM CYP1A1 83/4885CYP1B1 307/4885HCRTR1 3750/4885
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME L1CAM, C1S, F10 CYP1A1 241/4885CYP1B1 659/4885HCRTR1 3355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.